Logo image of MGN.OL

MAGNORA ASA (MGN.OL) Stock Fundamental Analysis

OSL:MGN - Euronext Oslo - NO0010187032 - Common Stock - Currency: NOK

22.5  +0.9 (+4.17%)

Fundamental Rating

5

MGN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 21 industry peers in the Independent Power and Renewable Electricity Producers industry. MGN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. MGN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year MGN was profitable.
Of the past 5 years MGN 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: MGN reported negative operating cash flow in multiple years.
MGN.OL Yearly Net Income VS EBIT VS OCF VS FCFMGN.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M

1.2 Ratios

The Return On Assets of MGN (95.90%) is better than 100.00% of its industry peers.
MGN has a better Return On Equity (129.55%) than 100.00% of its industry peers.
MGN has a Return On Invested Capital of 40.57%. This is amongst the best in the industry. MGN outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 95.9%
ROE 129.55%
ROIC 40.57%
ROA(3y)45.75%
ROA(5y)25.52%
ROE(3y)62.41%
ROE(5y)34.96%
ROIC(3y)N/A
ROIC(5y)N/A
MGN.OL Yearly ROA, ROE, ROICMGN.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

The Profit Margin of MGN (11786.27%) is better than 100.00% of its industry peers.
MGN's Profit Margin has improved in the last couple of years.
The Operating Margin of MGN (4870.59%) is better than 100.00% of its industry peers.
Industry RankSector Rank
OM 4870.59%
PM (TTM) 11786.27%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y250.83%
GM growth 3YN/A
GM growth 5YN/A
MGN.OL Yearly Profit, Operating, Gross MarginsMGN.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K 10K 15K 20K 25K

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MGN is creating value.
The number of shares outstanding for MGN has been reduced compared to 1 year ago.
MGN has more shares outstanding than it did 5 years ago.
MGN has a worse debt/assets ratio than last year.
MGN.OL Yearly Shares OutstandingMGN.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MGN.OL Yearly Total Debt VS Total AssetsMGN.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

MGN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC4.75
WACC8.54%
MGN.OL Yearly LT Debt VS Equity VS FCFMGN.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 2.37 indicates that MGN has no problem at all paying its short term obligations.
The Current ratio of MGN (2.37) is better than 85.71% of its industry peers.
A Quick Ratio of 2.37 indicates that MGN has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.37, MGN belongs to the best of the industry, outperforming 90.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 2.37
MGN.OL Yearly Current Assets VS Current LiabilitesMGN.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

MGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 210.84%, which is quite impressive.
The Earnings Per Share has been growing by 87.45% on average over the past years. This is a very strong growth
The Revenue for MGN has decreased by -80.99% in the past year. This is quite bad
The Revenue for MGN have been decreasing by -43.96% on average. This is quite bad
EPS 1Y (TTM)210.84%
EPS 3YN/A
EPS 5Y87.45%
EPS Q2Q%-11.57%
Revenue 1Y (TTM)-80.99%
Revenue growth 3Y-46.71%
Revenue growth 5Y-43.96%
Sales Q2Q%134.21%

3.2 Future

MGN is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -3.93% yearly.
MGN is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -24.73% yearly.
EPS Next Y-21.58%
EPS Next 2Y28.37%
EPS Next 3Y-3.93%
EPS Next 5YN/A
Revenue Next Year-26.54%
Revenue Next 2Y21.48%
Revenue Next 3Y-24.73%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MGN.OL Yearly Revenue VS EstimatesMGN.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
MGN.OL Yearly EPS VS EstimatesMGN.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

MGN is valuated cheaply with a Price/Earnings ratio of 5.37.
95.24% of the companies in the same industry are more expensive than MGN, based on the Price/Earnings ratio.
MGN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.79.
With a Price/Forward Earnings ratio of 6.85, the valuation of MGN can be described as very cheap.
Based on the Price/Forward Earnings ratio, MGN is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MGN to the average of the S&P500 Index (21.38), we can say MGN is valued rather cheaply.
Industry RankSector Rank
PE 5.37
Fwd PE 6.85
MGN.OL Price Earnings VS Forward Price EarningsMGN.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MGN indicates a rather cheap valuation: MGN is cheaper than 85.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.15
MGN.OL Per share dataMGN.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The decent profitability rating of MGN may justify a higher PE ratio.
A cheap valuation may be justified as MGN's earnings are expected to decrease with -3.93% in the coming years.
PEG (NY)N/A
PEG (5Y)0.06
EPS Next 2Y28.37%
EPS Next 3Y-3.93%

More info and screens

0

5. Dividend

5.1 Amount

MGN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAGNORA ASA

OSL:MGN (4/25/2025, 7:00:00 PM)

22.5

+0.9 (+4.17%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)04-25 2025-04-25
Earnings (Next)07-18 2025-07-18
Inst Owners11.34%
Inst Owner ChangeN/A
Ins Owners5.78%
Ins Owner ChangeN/A
Market Cap1.48B
Analysts85
Price Target38.42 (70.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend4.62
Dividend Growth(5Y)0.46%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)11.61%
Min EPS beat(2)-11.19%
Max EPS beat(2)34.4%
EPS beat(4)1
Avg EPS beat(4)-114.48%
Min EPS beat(4)-379.21%
Max EPS beat(4)34.4%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)32.68%
Min Revenue beat(2)20.97%
Max Revenue beat(2)44.39%
Revenue beat(4)3
Avg Revenue beat(4)48.53%
Min Revenue beat(4)-37.29%
Max Revenue beat(4)166.04%
Revenue beat(8)5
Avg Revenue beat(8)262.59%
Revenue beat(12)7
Avg Revenue beat(12)294.3%
Revenue beat(16)10
Avg Revenue beat(16)289.83%
PT rev (1m)0.89%
PT rev (3m)0.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)13.94%
EPS NY rev (3m)30.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 5.37
Fwd PE 6.85
P/S 290.21
P/FCF N/A
P/OCF N/A
P/B 3.19
P/tB 4.8
EV/EBITDA 4.15
EPS(TTM)4.19
EY18.62%
EPS(NY)3.28
Fwd EY14.59%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.08
BVpS7.05
TBVpS4.69
PEG (NY)N/A
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 95.9%
ROE 129.55%
ROCE 52.69%
ROIC 40.57%
ROICexc 177.59%
ROICexgc N/A
OM 4870.59%
PM (TTM) 11786.27%
GM N/A
FCFM N/A
ROA(3y)45.75%
ROA(5y)25.52%
ROE(3y)62.41%
ROE(5y)34.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y250.83%
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.37
Quick Ratio 2.37
Altman-Z N/A
F-ScoreN/A
WACC8.54%
ROIC/WACC4.75
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)19.76%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)210.84%
EPS 3YN/A
EPS 5Y87.45%
EPS Q2Q%-11.57%
EPS Next Y-21.58%
EPS Next 2Y28.37%
EPS Next 3Y-3.93%
EPS Next 5YN/A
Revenue 1Y (TTM)-80.99%
Revenue growth 3Y-46.71%
Revenue growth 5Y-43.96%
Sales Q2Q%134.21%
Revenue Next Year-26.54%
Revenue Next 2Y21.48%
Revenue Next 3Y-24.73%
Revenue Next 5YN/A
EBIT growth 1Y4257.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-19.3%
EBIT Next 3Y-8.1%
EBIT Next 5YN/A
FCF growth 1Y-4100%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3596.67%
OCF growth 3YN/A
OCF growth 5YN/A